Familial dysautonomia (FD; Riley-Day syndrome) is the best know and most frequent of a group of congenital sensory neuropathies characterized by widespread sensory and variable autonomic dysfunction. First described in 1949. FD is devastating disorder that involves progressive neuronal degeneration with a broad impact on the operation of many of the body's systems leading to a vastly reduced quality of life and premature death. Affected individuals demonstrate lack of overflow tears, impaired temperature and pain sensation, and autonomic dysfunction, including labile blood pressure and uncoordinated swallowing. Despite recent advances in the management of FD, the disorder is inevitably fatal with only 50% of patients reaching 30 years of age. FD is due to a recessive genetic defect with a remarkably high carrier frequency in Ashkenazi Jews of 1 in 30, rivaling the gene frequencies of more widely recognized disorders such as Tay-Sachs disease and cystic fibrosis. FD's genetic characteristics make it ideally suite for molecular investigation. We have used genetic linkage to map the defective gene to chromosome 9q31 and have determined that its ethnic bias is due to a founder effect, with most disease alleles sharing a common ancestral mutation. This has provided a strategy for narrowing the location of the disease gene to a small stretch of genomic DNA. We are now poised to identify the nature of the genetic defect in FD and to characterize its mode of pathogenesis. The product of this work will be a knowledge of the cause of FD and its relationship to other sensory neuropathies, the ability to screen for carriers of the disorder, and the beginning to the exploration of the normal and abnormal function of the DYS gene in human and animal model systems. In the long-term we will contribute both to the fundamental understanding of development and maintenance of the sensory and autonomic nervous systems, and to the hope of FD patients for an effective treatment preventing progression of this devastating disorder.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS036326-03
Application #
2892242
Study Section
Genome Study Section (GNM)
Program Officer
Spinella, Giovanna M
Project Start
1997-04-15
Project End
2000-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Morini, Elisabetta; Dietrich, Paula; Salani, Monica et al. (2016) Sensory and autonomic deficits in a new humanized mouse model of familial dysautonomia. Hum Mol Genet 25:1116-28
Axelrod, Felicia B; Liebes, Leonard; Gold-Von Simson, Gabrielle et al. (2011) Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia. Pediatr Res 70:480-3
Shetty, Ranjit S; Gallagher, Cary S; Chen, Yei-Tsung et al. (2011) Specific correction of a splice defect in brain by nutritional supplementation. Hum Mol Genet 20:4093-101
Hims, Matthew M; Shetty, Ranjit S; Pickel, James et al. (2007) A humanized IKBKAP transgenic mouse models a tissue-specific human splicing defect. Genomics 90:389-96
Cuajungco, Math P; Leyne, Maire; Mull, James et al. (2003) Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia. Am J Hum Genet 72:749-58
Fini, M Elizabeth; Slaugenhaupt, Susan A (2002) Enzymatic mechanisms in corneal ulceration with specific reference to familial dysautonomia: potential for genetic approaches. Adv Exp Med Biol 506:629-39
Slaugenhaupt, Susan A (2002) Genetics of familial dysautonomia. Tissue-specific expression of a splicing mutation in the IKBKAP gene. Clin Auton Res 12 Suppl 1:I15-9
Slaugenhaupt, S A; Blumenfeld, A; Gill, S P et al. (2001) Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 68:598-605
Cuajungco, M P; Leyne, M; Mull, J et al. (2001) Cloning, characterization, and genomic structure of the mouse Ikbkap gene. DNA Cell Biol 20:579-86
Chadwick, B P; Leyne, M; Gill, S et al. (2000) Cloning, mapping, and expression of a novel brain-specific transcript in the familial dysautonomia candidate region on chromosome 9q31. Mamm Genome 11:81-3

Showing the most recent 10 out of 14 publications